WTB
VRTX icon

Washington Trust Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Washington Trust Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Sell
21,320
-3,603
-14% -$1.6M 0.74% 34
2026
Q1 		$11.1M Sell
24,923
-4,916
-16% -$2.29M 0.82% 36
2025
Q4 		$13.5M Buy
29,839
+30
+0.1% +$12.9K 0.95% 31
2025
Q3 		$11.7M Buy
29,809
+566
+2% +$237K 0.86% 34
2025
Q2 		$13M Buy
29,243
+943
+3% +$435K 1.1% 29
2025
Q1 		$13.7M Sell
28,300
-1,511
-5% -$704K 1.37% 26
2024
Q4 		$12M Sell
29,811
-1,460
-5% -$677K 1.15% 32
2024
Q3 		$14.5M Sell
31,271
-1,752
-5% -$842K 1.39% 25
2024
Q2 		$15.5M Sell
33,023
-1,146
-3% -$497K 1.53% 24
2024
Q1 		$14.3M Sell
34,169
-1,892
-5% -$800K 1.36% 26
2023
Q4 		$14.7M Sell
36,061
-2,315
-6% -$855K 1.3% 25
2023
Q3 		$13.3M Sell
38,376
-1,869
-5% -$654K 1.39% 25
2023
Q2 		$14.2M Sell
40,245
-819
-2% -$276K 1.45% 24
2023
Q1 		$12.9M Buy
41,064
+6,845
+20% +$2.05M 1.38% 23
2022
Q4 		$9.88M Buy
+34,219
New +$10.4M 1.12% 29
2019
Q2 		– Sell
-100
Closed -$18K – 535
2019
Q1 		$18K Hold
100
– – ﹤0.01% 450
2018
Q4 		$17K Hold
100
– – ﹤0.01% 449
2018
Q3 		$19K Hold
100
– – ﹤0.01% 482
2018
Q2 		$17K Hold
100
– – ﹤0.01% 486
2018
Q1 		$16K Buy
+100
New +$16.3K ﹤0.01% 537
2017
Q1 		– Sell
-20
Closed -$1K – 968
2016
Q4 		$1K Sell
20
-16
-44% -$1.3K ﹤0.01% 919
2016
Q3 		$3K Sell
36
-28
-44% -$2.65K ﹤0.01% 679
2016
Q2 		$6K Sell
64
-13
-17% -$1.12K ﹤0.01% 617
2016
Q1 		$6K Buy
77
+27
+54% +$2.44K ﹤0.01% 626
2015
Q4 		$6K Hold
50
– – ﹤0.01% 645
2015
Q3 		$5K Sell
50
-50
-50% -$6.42K ﹤0.01% 683
2015
Q2 		$12K Hold
100
– – ﹤0.01% 649
2015
Q1 		$12K Buy
+100
New +$12K ﹤0.01% 662

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Washington Trust Bank's VRTX Position: Q2 2026 in Review

Washington Trust Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q2 2026, selling an estimated $1.6M and leaving 21,320 shares worth $10.6M. The position accounts for 0.74% of the portfolio, ranked #34.

Washington Trust Bank first reported a position in VRTX in Q1 2015 and has held it in 28 quarters since. The position peaked at $15.5M in Q2 2024. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Washington Trust Bank held 21,320 shares of Vertex Pharmaceuticals worth $10.6M as of Q2 2026.
  • Washington Trust Bank sold 3,603 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.6M.
  • Vertex Pharmaceuticals made up 0.74% of Washington Trust Bank's portfolio in Q2 2026, its #34 holding.
  • Washington Trust Bank first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 28 quarters since.
  • Washington Trust Bank's Vertex Pharmaceuticals position peaked at $15.5M in Q2 2024.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Washington Trust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.